The restrictions intended to improve patient safety created a market that was, in many ways, less safe
Research Compound Summary Compound: GHK-Cu CAS Number: 49557-75-7 Molecular Formula: C14H23CuN6O4 Purity: 99.56% (HPLC-UV verified) Third-Party Testing: Testides Analytical (independent lab, Toronto) COA Download: View Full COA (PDF) Report: DBAV-GHK-Cu-50-062226 Lot Number: 5816 Source: Canadian manufactured Shipping: Same-day from our BC facility GHK-Cu peptide Canada: a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) complexed with copper(II) ions
F2-isoprostanes (F2-IsoPs) are potent vasoconstrictors (35)These compounds are similar to prostaglandins, and they are produced during non-enzymatic ROS peroxidation of polyunsaturated fatty acids (PUFAs), mainly arachidonic acid
Cumulus cells apoptosis as an indicator to predict the quality of oocytes and the outcome of IVF-ET
Safety and Tolerability Profile BPC-157 Safety Profile: (PMID: 32334036, PMID: 25415472, PMID: 31158953) Preclinical Toxicity: Extremely low toxicity
If needed for a clear medical indication (such as treating pellagra in a pregnant patient), niacinamide can be used with caution, but unnecessary high-dose B supplementation is avoided in pregnancy